DE60137082D1 - Zusammensetzungen von arginin mit kontrollierter freigabe - Google Patents

Zusammensetzungen von arginin mit kontrollierter freigabe

Info

Publication number
DE60137082D1
DE60137082D1 DE60137082T DE60137082T DE60137082D1 DE 60137082 D1 DE60137082 D1 DE 60137082D1 DE 60137082 T DE60137082 T DE 60137082T DE 60137082 T DE60137082 T DE 60137082T DE 60137082 D1 DE60137082 D1 DE 60137082D1
Authority
DE
Germany
Prior art keywords
arginine
compositions
controlled release
pahtways
biotransformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60137082T
Other languages
English (en)
Inventor
Wayne H Kaesemeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palmetto Pharmaceuticals LLC
Original Assignee
Palmetto Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palmetto Pharmaceuticals LLC filed Critical Palmetto Pharmaceuticals LLC
Application granted granted Critical
Publication of DE60137082D1 publication Critical patent/DE60137082D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE60137082T 2000-06-28 2001-06-28 Zusammensetzungen von arginin mit kontrollierter freigabe Expired - Fee Related DE60137082D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60559900A 2000-06-28 2000-06-28
PCT/US2001/020887 WO2002000212A1 (en) 2000-06-28 2001-06-28 Controlled release arginine formulations

Publications (1)

Publication Number Publication Date
DE60137082D1 true DE60137082D1 (de) 2009-01-29

Family

ID=24424380

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137082T Expired - Fee Related DE60137082D1 (de) 2000-06-28 2001-06-28 Zusammensetzungen von arginin mit kontrollierter freigabe

Country Status (8)

Country Link
EP (1) EP1377284B1 (de)
JP (1) JP2004513877A (de)
AT (1) ATE417609T1 (de)
AU (1) AU2001271700A1 (de)
CA (1) CA2413816A1 (de)
DE (1) DE60137082D1 (de)
MX (1) MXPA03000194A (de)
WO (1) WO2002000212A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002539257A (ja) 1999-03-19 2002-11-19 イーノス・ファーマシューティカルス・インコーポレーテッド 薬剤の脳内生物学的利用率の増加
WO2003075893A1 (en) * 2002-03-04 2003-09-18 Teva Pharmaceutical Industries Ltd. Controlled release dosage forms
CA2540202A1 (en) * 2003-09-29 2005-04-21 Enos Pharmaceuticals, Inc. Sustained release l-arginine formulations and methods of manufacture and use
JP2010270111A (ja) * 2009-04-21 2010-12-02 Taisho Pharmaceutical Co Ltd アルギニン含有錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2827287B2 (ja) * 1988-07-05 1998-11-25 武田薬品工業株式会社 水溶性薬物含有徐放型マイクロカプセル
JPH04504122A (ja) * 1989-03-17 1992-07-23 ピットマン―ムーア・インコーポレイテッド 巨大分子タンパク質の制御放出考案物
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5968983A (en) * 1994-10-05 1999-10-19 Nitrosystems, Inc Method and formulation for treating vascular disease
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
JP2002539257A (ja) * 1999-03-19 2002-11-19 イーノス・ファーマシューティカルス・インコーポレーテッド 薬剤の脳内生物学的利用率の増加
AU1800801A (en) * 1999-11-17 2001-05-30 Eric H. Kuhrts Exercise and muscle enhancement formulations

Also Published As

Publication number Publication date
MXPA03000194A (es) 2004-09-13
AU2001271700A1 (en) 2002-01-08
ATE417609T1 (de) 2009-01-15
WO2002000212A1 (en) 2002-01-03
JP2004513877A (ja) 2004-05-13
EP1377284B1 (de) 2008-12-17
CA2413816A1 (en) 2002-01-03
EP1377284A1 (de) 2004-01-07
EP1377284A4 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
AU2603400A (en) Formulations for treating disease and methods of using same
AR023427A1 (es) Adhesivos de fundido en caliente basados en poliesteres sulfonados que incluyen un indicador de humedad.
CR20110356A (es) Bioconversion estereoselectiva de dinitrilos alifaticos en acidos cianocarboxilicos (divisional exp. 8686)
IDP000022475A (id) Emulsi-mikro dan metoda
AU2001279703A1 (en) Garment
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
ATE314084T1 (de) Kahalalid f formulierung
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
ES2189657B1 (es) Composiciones de resina plaguicidas.
ATE417609T1 (de) Zusammensetzungen von arginin mit kontrollierter freigabe
BR0213536A (pt) Formulações de xarope de ribavirina
DE60110814D1 (de) Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat
MXPA02010028A (es) Hipotensores.
BR0010499A (pt) Agentes endoparasiticidas
PT1299114E (pt) Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
RS50711B (sr) Insekticidna kompozicija koja ima poboljšanu skladišnu stabilnost
ATE298502T1 (de) Desinfektionsmittel mit antiparasitärer wirkung
MY135472A (en) Oil-barrier composition
AU2001236204A1 (en) Ironing device and iron
WO2001059743A3 (en) Guide-map shirt
BR0101772A (pt) Agente espessante e estabilizador de espuma
RS53223B (en) METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C
SE9901442L (sv) Ny användning
AU132015S (en) Pants
BR0106346A (pt) Aperfeiçoamento em tecido ìndigo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee